Read more

February 19, 2021
1 min read
Save

Top in GI: Acute pancreatitis and COVID-19, PPI use and asthma risk

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A recent study demonstrated an increased risk for organ failure and mortality among patients with acute pancreatitis and COVID-19. It was the top story in gastroenterology last week.

Another top story was about a link between proton pump inhibitor (PPI) use and asthma risk among children. The risk for asthma was greatest among infants and toddlers aged younger than 2 years.

Hospital beds in a hospital
Source: Adobe Stock

Read these and more top stories in gastroenterology below:

Acute pancreatitis, SARS-CoV-2 increase risk for disease severity

Patients with coexistent acute pancreatitis and SARS-CoV-2 infection had an increased risk for severe acute pancreatitis and worse clinical outcomes, according to study results. Read more.

PPI use increases risk for asthma by 57% in children

The risk for asthma in children grew with use of PPIs compared with no use, according to a study published in JAMA Pediatrics. Read more.

7 recent reports on COVID-19 in gastroenterology

Healio recently compiled a list of stories on the intersection of COVID-19 and gastroenterology. The articles include new research on how gut microbiome composition interacts with COVID-19 severity. Read more.

High rate of COVID-19 vaccination intent among IBD populations

A relatively high rate of COVID-19 vaccination intent was observed among inflammatory bowel disease populations; however, long-term safety concerns were common, according to study results. Read more.

No benefit from famotidine on COVID-19 outcomes

There was no reduced risk for COVID-19 outcomes among hospitalized patients treated with famotidine, according to study results. Read more.